Replies to post #3289 on Insmed Inc (INSM)

[Do DD]

Intherest,

Firstly: it was mentioned yesterday in the CC.

The general link is:

The third International Congress of the GRS and the IGF society
http://www.congre.co.jp/3grs-igf/

Also the following posts by Biowatchdog and Soulmark52 on Yahoo give more info:


Where is Tercica's booth?

Exhibitors List :

E-1 Pfizer
E-2 Insmed
E-3 Eli Lilly and Company
E-4 Novo Nordisk Pharma
E-5 Serono International
E-6 Dainippon Sumitomo Pharma

Re: Info Coup
That's it, but inside...

The week of November 11 or the next may great us with a bombardment of good news! Fasten your seat belts! This is just a sampling with the relevant new formulation of iPlex and the Cecilia Camacho-Hübner study. I've also thrown in some Clemmon's March info. There are sevral more BP3 study presentations, but I leave that for all of you to read...the first link is the goody. Enjoy!

http://www.congre.co.jp/3grs-igf/images/program.pdf
PO14 IGF Clinical/Therapy
LP-92 Stability of rhIGF-I/rhIGFBP-3 under common storage conditions Kenneth M. Attie Dept. of Medical Affairs, Insmed Inc., Richmond, VA,
USA

OR08-4 The IGFBP-3 partner, humanin, protects beta cells from apoptosis in vitro and improves glucose tolerance in the NOD model in vivo Kuk-Wha Lee Department of Pediatric Endocrinology, Mattel Children's Hospital at University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, USA

OR08-3 Effects of insulin-like growth factor binding protein-3 on human malignant pleural mesothelioma cell growth and apoptosis Cecilia Camacho-Hübner Department of Endocrinology, William Harvey Research Institute and St Bartholomew's Hospital, University of London, London, UK

http://grc.org/programs/2007/insulin.htm

David Clemmons a Lead investigator for Insmed...diabetes

Re: Info Coup

No takers on the OR08-4 presentation?

"IGFBP-3 partner, humanin, protects beta cells from apoptosis in vitro and improves glucose tolerance in the NOD model"

If IGFBP-3 "holds" humanin for delivery...Alzheimer’s
http://www.pepnet.com/humanin.html


Therefore: a lot of interesting news: as you can see the Alzheimer stuff is still in mice tests just like the Herceptin/BP3 Breastcancer tests discussed here a couple of months ago. But again it's a sign of the possibilities INSMEDs product portfolio brings.
Also: nice to see that INSMED is exhibiting between big guns in pharma, it's a recognition of the eminent work done by INSM in the field.

E.